Overview

MD Ezetimibe Cyclosporine Interaction (0653-057)

Status:
Completed

Trial end date:
2004-01-01

Target enrollment:

Participant gender:

Summary

Study to determine the effect of multiple oral doses of ezetimibe on the pharmacokinetics of a single oral dose cyclosporine in young healthy males and females.

Phase:

Phase 1

Details

Lead Sponsor:

Merck Sharp & Dohme Corp.

Collaborator:

Schering-Plough

Treatments:

Cyclosporine
Cyclosporins
Ezetimibe